Dermatology · Estero, FL
NPI
1487625885
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10200 Arcos Ave Ste 201
Estero, FL, 33928
Phone (239) 390-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
30,516 services
Medicare patients, 2024
3,397
Average age 76
Drug cost, 2024
$55K
4,107 prescriptions
Company payments, 2025
$299
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory M Houck was code 17003 (destruction skin lesion), 7,740 times for 1,256 patients. In total Gregory M Houck billed 30,516 services in 104 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 7,740 | 1,256 | $5.19 | $40K |
| 99213 Office E&M - Established | Office | 4,460 | 2,310 | $66.28 | $296K |
| 11102 Skin Biopsy | Office | 2,903 | 1,947 | $67.60 | $196K |
| 17000 Destruction Skin Lesion | Office | 2,280 | 1,529 | $35.90 | $82K |
| 11103 Skin Biopsy | Office | 2,037 | 1,004 | $40.54 | $83K |
| Q4197 Puraply xt, per square centimeter | Office | 1,161 | 20 | $86.88 | $101K |
| 17110 Destruction Skin Lesion | Office | 975 | 758 | $83.13 | $81K |
| 17004 Destruction Skin Lesion | Office | 837 | 544 | $132.47 | $111K |
| 99203 Office E&M - New | Office | 743 | 743 | $71.16 | $53K |
| 99212 Office E&M - Established | Office | 675 | 545 | $43.67 | $29K |
| 96910 Skin | Office | 549 | 22 | $95.46 | $52K |
| 13132 Wound Repair - All Levels | Office | 362 | 306 | $375.22 | $136K |
| 17262 Destruction Skin Lesion | Office | 347 | 263 | $128.04 | $44K |
| 11301 Removal or Shaving of Skin Growth | Office | 347 | 229 | $78.88 | $27K |
| 13121 Wound Repair - All Levels | Office | 305 | 269 | $339.37 | $104K |
By year: 2022 $986K for 14,353 services; 2023 $1.4M for 23,787 services; 2024 $2.0M for 30,516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory M Houck prescribed most often to Medicare patients was Gentamicin Sulfate, with 1,784 prescriptions and refills. In total Gregory M Houck wrote 4,107 Medicare prescriptions that cost $55K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gentamicin Sulfate Generic | 1,784 | 1,786 | 1,370 | $33K |
| Doxycycline Hyclate Generic | 1,725 | 1,727 | 1,347 | $12K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 135 | 135 | 103 | $1,032 |
| Triamcinolone Acetonide Generic | 126 | 143 | 98 | $842 |
| Ketoconazole Generic | 55 | 61 | 35 | $920 |
| Mupirocin Generic | 47 | 47 | 37 | $382 |
| Fluorouracil Generic | 34 | 36 | 28 | $1,798 |
| Clobetasol Propionate Generic | 27 | 27 | 18 | $1,101 |
| Ciclopirox Ciclopirox Olamine | 24 | 28 | 18 | $428 |
| Nystatin Generic | 24 | 27 | 19 | $274 |
| Betamethasone Dipropionate Generic | 19 | 23 | Under 11 | $715 |
| Clindamycin Phosphate Generic | 16 | 18 | 11 | $230 |
| Valacyclovir Valacyclovir Hcl | 15 | 16 | 14 | $462 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 14 | 15 | 11 | $77.69 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | 11 | $57.29 |
Brand drugs: 46 claims; generic drugs: 4,061 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory M Houck $299 ($299 in general payments such as food, travel and fees) from 6 companies. The largest payer was Organogenesis Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. ORGO | 9 | $152 |
| Abbvie Inc. ABBV | 2 | $43.6 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $35.13 |
| Kerecis Limited | 1 | $29.41 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $20.64 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.